Skip to content
Catalyst

PapersPMID:37404567

Effects of Bifidobacterium longum CLA8013 on bowel movement improvement: a placebo-controlled, randomized, double-blind study.

Bioscience of microbiota, food and health2023The record ↗

  1. Finding, moderate evidenceraisesStool frequency

What moved

1 findingHow to read these marks →
  • “The primary endpoint, change in defecation frequency, was significantly increased in the treatment group compared with that in the control group after 2 weeks of B. longum CLA8013 consumption (p=0.048), with an increase of 1.16 ± 1.93 times/week.”
    Study
    RCT
    Duration
    14 days
    Interests
    Industry funded
    Dose studied
    one capsule per day after dinner, 25 billion CFU, oral, 2 weeks
    Population
    Healthy adults aged 20-65 prone to constipation (3-5 spontaneous bowel movements per week, mean Bristol Stool Form Scale below 4); per-protocol set of 104

Study record

Design
randomised controlled trial
Species
human
Population
constipation-prone healthy adults
Participants
120
Comparator
placebo
Duration
14 days
Endpoints measured
44